MAIA Biotechnology Inc (MAIA)
3.22
+0.07
(+2.22%)
USD |
NYAM |
May 03, 16:00
3.22
0.00 (0.00%)
After-Hours: 19:43
MAIA Biotechnology Total Return Level: 3.15 for May 2, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
May 02, 2024 | 3.15 |
May 01, 2024 | 2.92 |
April 30, 2024 | 2.93 |
April 29, 2024 | 3.21 |
April 26, 2024 | 2.94 |
April 25, 2024 | 2.68 |
April 24, 2024 | 2.69 |
April 23, 2024 | 2.46 |
April 22, 2024 | 2.26 |
April 19, 2024 | 2.15 |
April 18, 2024 | 1.96 |
April 17, 2024 | 1.98 |
April 16, 2024 | 2.06 |
April 15, 2024 | 2.04 |
April 12, 2024 | 2.205 |
April 11, 2024 | 2.43 |
April 10, 2024 | 2.46 |
April 09, 2024 | 2.57 |
April 08, 2024 | 2.49 |
April 05, 2024 | 2.35 |
April 04, 2024 | 2.20 |
April 03, 2024 | 2.32 |
April 02, 2024 | 2.35 |
April 01, 2024 | 2.48 |
March 28, 2024 | 2.20 |
Date | Value |
---|---|
March 27, 2024 | 2.48 |
March 26, 2024 | 2.44 |
March 25, 2024 | 2.55 |
March 22, 2024 | 2.11 |
March 21, 2024 | 1.94 |
March 20, 2024 | 1.65 |
March 19, 2024 | 1.69 |
March 18, 2024 | 1.50 |
March 15, 2024 | 1.39 |
March 14, 2024 | 1.31 |
March 13, 2024 | 1.340 |
March 12, 2024 | 1.31 |
March 11, 2024 | 1.298 |
March 08, 2024 | 1.33 |
March 07, 2024 | 1.40 |
March 06, 2024 | 1.47 |
March 05, 2024 | 1.48 |
March 04, 2024 | 1.45 |
March 01, 2024 | 1.395 |
February 29, 2024 | 1.31 |
February 28, 2024 | 1.38 |
February 27, 2024 | 1.36 |
February 26, 2024 | 1.37 |
February 23, 2024 | 1.38 |
February 22, 2024 | 1.47 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
0.83
Minimum
Dec 12 2023
7.80
Maximum
Aug 01 2022
2.726
Average
2.45
Median
Total Return Level Benchmarks
Cyclacel Pharmaceuticals Inc | 2.48 |
Avid Bioservices Inc | 8.21 |
Oragenics Inc | 1.050 |
NeuBase Therapeutics Inc | 0.4121 |
Viking Therapeutics Inc | 75.76 |